G Praxen And Co Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 05-07-2024
- Paid Up Capital ₹ 4.00 M
as on 05-07-2024
- Company Age 77 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.41 M
as on 05-07-2024
- Revenue -3.89%
(FY 2019)
- Profit -14.09%
(FY 2019)
- Ebitda 426.91%
(FY 2019)
- Net Worth 2.69%
(FY 2019)
- Total Assets 6.25%
(FY 2019)
About G Praxen And Co
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.41 M.
Siddhant Saxena, Vineet Saxena, Viranjani Saxena, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231UP1947PTC001716
- Company No.
001716
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 1947
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at G Praxen And Co?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddhant Saxena | Director | 31-Mar-2024 | Current |
Vineet Saxena  | Director | 29-Sep-1993 | Current |
| Viranjani Saxena | Director | 30-Jun-1978 | Current |
| Sumeet Saxena | Director | 29-Sep-1993 | Current |
Financial Performance and Corporate Structure Insights of G Praxen And Co.
G Praxen And Co Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 3.89% decrease. The company also saw a substantial fall in profitability, with a 14.09% decrease in profit. The company's net worth moved up by a moderate rise of 2.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G Praxen And Co?
In 2018, G Praxen And Co had a promoter holding of 78.09% and a public holding of 21.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
G. Praxen Pharmaceutical Private Limited
Active
5 years 9 months Siddhant Saxena, Vineet Saxena and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 08 Oct 1998 | ₹0.11 M | Open |
State Bank Of India Creation Date: 08 Oct 1998 | ₹0.20 M | Open |
State Bank Of India Creation Date: 04 Aug 1993 | ₹0.40 M | Open |
How Many Employees Work at G Praxen And Co?
G Praxen And Co has a workforce of 4 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Apr 10, 2015, G Praxen And Co has raised a total of ₹ 2.5 M, with the most recent deal valued at ₹ 1.75 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
